These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23890253)

  • 1. Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation.
    Koldehoff M; Beelen DW; Elmaagacli AH
    Transpl Infect Dis; 2013 Oct; 15(5):533-9. PubMed ID: 23890253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.
    Bochud PY; Chien JW; Marr KA; Leisenring WM; Upton A; Janer M; Rodrigues SD; Li S; Hansen JA; Zhao LP; Aderem A; Boeckh M
    N Engl J Med; 2008 Oct; 359(17):1766-77. PubMed ID: 18946062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation.
    Kesh S; Mensah NY; Peterlongo P; Jaffe D; Hsu K; VAN DEN Brink M; O'reilly R; Pamer E; Satagopan J; Papanicolaou GA
    Ann N Y Acad Sci; 2005 Dec; 1062():95-103. PubMed ID: 16461792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
    Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
    Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR5 stop codon polymorphism is associated with invasive aspergillosis after allogeneic stem cell transplantation.
    Grube M; Loeffler J; Mezger M; Krüger B; Echtenacher B; Hoffmann P; Edinger M; Einsele H; Andreesen R; Holler E
    Med Mycol; 2013 Nov; 51(8):818-25. PubMed ID: 23862689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantation.
    de Boer MG; Jolink H; Halkes CJ; van der Heiden PL; Kremer D; Falkenburg JH; van de Vosse E; van Dissel JT
    PLoS One; 2011 Apr; 6(4):e18403. PubMed ID: 21483748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenetics of invasive aspergillosis.
    Lamoth F; Rubino I; Bochud PY
    Med Mycol; 2011 Apr; 49 Suppl 1():S125-36. PubMed ID: 20840014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
    Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
    Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Aspergillus-specific immune recovery between T-cell-replete and T-cell-depleted hematopoietic transplants.
    Perruccio K; Topini F; Tosti A; Gazzola MV; Messina C; Martelli MF; Caniglia M; Velardi A; Cesaro S
    Eur J Haematol; 2015 Dec; 95(6):551-7. PubMed ID: 25688598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preventing invasive aspergillosis in hematopoietic stem cells transplant recipients].
    Lamoth F; Bochud PY
    Med Sci (Paris); 2009; 25(8-9):669-72. PubMed ID: 19765376
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
    Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
    Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility to aspergillosis in allogeneic stem-cell transplantation.
    Cunha C; Rodrigues F; Zelante T; Aversa F; Romani L; Carvalho A
    Med Mycol; 2011 Apr; 49 Suppl 1():S137-43. PubMed ID: 20718605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
    Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
    Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired T cell responsiveness to interleukin-6 in hematological patients with invasive aspergillosis.
    Camargo JF; Bhimji A; Kumar D; Kaul R; Pavan R; Schuh A; Seftel M; Lipton JH; Gupta V; Humar A; Husain S
    PLoS One; 2015; 10(4):e0123171. PubMed ID: 25835547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
    Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of the association of the expression and single nucleotide polymorphisms (SNPs) of the TLR4, PTX3 and Dectin-1 (CLEC/A) genes with development of invasive aspergillosis among haematopoietic stem cell transplant recipients with oncohaematological disorders.
    Kalkanci A; Tug E; Fidan I; Guzel Tunccan O; Ozkurt ZN; Yegin ZA; Sahin EA; Kuralay Z
    Mycoses; 2020 Aug; 63(8):832-839. PubMed ID: 32291814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.